Skip to main content

Featured

Budget 2026 Consultations Are Open — Here's What Canadians Should Ask For

July 7, 2026 Ottawa wants your input on Budget 2026 before September 8. Here's what the consultation actually is, why it matters to your wallet, and what to say if you take part. The bottom line: On July 6, Finance Minister François-Philippe Champagne launched pre-budget consultations for this fall's federal budget. Canadians can submit input online until September 8, 2026 at Canada.ca/yourbudget. It's a rare, direct window to flag what's actually squeezing your household before the government finalizes tax, benefit, and spending decisions for next year. What Just Happened The Department of Finance officially opened the pre-budget consultation process for Budget 2026, which will be tabled this fall. The stated priorities are broad — boosting investment and competition, strengthening economic sovereignty, and addressing the "most pressing economic challenges facing Canadians today." Over the summer, Champagne, along with Secretary of State Wayne Long and Parl...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment